Novozymes A/S's ticker is NVZMY and the CUSIP is 670108109. A total of 11 filers reported holding Novozymes A/S in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $1,520,000 | -25.3% | 44,010 | -4.9% | 0.13% | -26.6% |
Q3 2016 | $2,036,000 | +3.1% | 46,280 | +11.9% | 0.18% | 0.0% |
Q2 2016 | $1,974,000 | +13.8% | 41,360 | +7.3% | 0.18% | +6.6% |
Q1 2016 | $1,735,000 | -7.3% | 38,540 | -0.9% | 0.17% | -9.3% |
Q4 2015 | $1,871,000 | +22.3% | 38,875 | +10.6% | 0.18% | +14.4% |
Q3 2015 | $1,530,000 | +4.9% | 35,145 | +14.6% | 0.16% | +12.7% |
Q2 2015 | $1,458,000 | – | 30,680 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lenox Wealth Management, Inc. | 62,488 | $2,907,000 | 0.87% |
ZEVIN ASSET MANAGEMENT LLC | 34,899 | $1,624,000 | 0.52% |
HIGH POINTE CAPITAL MANAGEMENT LLC | 5,090 | $238,000 | 0.33% |
BOSTON FINANCIAL MANGEMENT LLC | 108,846 | $5,065,000 | 0.29% |
Moloney Securities Asset Management, LLC | 15,263 | $713,000 | 0.24% |
Boston Common Asset Management, LLC | 24,577 | $1,148,000 | 0.14% |
Hemenway Trust Co LLC | 12,125 | $564,000 | 0.09% |
Renaissance Investment Group LLC | 5,000 | $234,000 | 0.09% |
QUADRANT CAPITAL GROUP LLC | 5,748 | $263,000 | 0.04% |
Douglass Winthrop Advisors, LLC | 6,902 | $321,000 | 0.01% |